farnesol and Neurofibromatosis 1

farnesol has been researched along with Neurofibromatosis 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barkan, B; Friedman, E; Kloog, Y; Starinsky, S; Stein, R	1

Other Studies

1 other study(ies) available for farnesol and Neurofibromatosis 1

Article	Year
The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-15, Volume: 12, Issue:18 Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Proliferation; Cytoskeleton; Drug Evaluation; Farnesol; Genes, Neurofibromatosis 1; Genes, ras; Humans; Male; Mice; Mice, Nude; Mutation; Nerve Sheath Neoplasms; Neurofibromatosis 1; Neurofibromin 1; ras Proteins; Salicylates; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2006

Article

Year

The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-15, Volume: 12, Issue:18

Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Proliferation; Cytoskeleton; Drug Evaluation; Farnesol; Genes, Neurofibromatosis 1; Genes, ras; Humans; Male; Mice; Mice, Nude; Mutation; Nerve Sheath Neoplasms; Neurofibromatosis 1; Neurofibromin 1; ras Proteins; Salicylates; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2006